PeerVoice Digestive Diseases Video PeerVoice

Visit https://www.peervoice.com/SSC860 to view the entire programme with slides. After completing “Marwan Fakih, MD - The Science and the Art of Sequencing Therapies in Advanced CRC Beyond the Second Line”, participants will be able to: Identify patients with advanced colorectal cancer (CRC) with disease progression who should be treated with later lines of therapy; Recognize patient-specific characteristics which guide choice and planning of later lines of treatment for advanced CRC; and Propose treatment regimens for patients with advanced CRC which has progressed on earlier lines of therapy.

Visit https://www.peervoice.com/AQR860 to view the entire programme with slides. After completing “Marwan Fakih, MD - Expert Lines of Thought in Sequencing Later Lines of Therapy in Advanced CRC”, participants will be able to: Describe current evidence-based standards of care in the management of advanced colorectal cancer (CRC); Evaluate emerging efficacy and safety data for treatment of advanced CRC beyond the second line; and Apply clinical data and guidelines to individualized sequencing of lines of therapy in advanced CRC.

Visit https://www.peervoice.com/GWC860 to view the entire programme with slides. After completing “Philip James Tozer, MBBS, MD(Res), FRCS - Multidisciplinary Perspectives on Advanced Management of CPF in CD: Exploring the Who, When, and How for Stem Cell Therapy”, participants will be able to: Evaluate efficacy and safety outcomes for advanced therapies, including stem cell therapy, which guide their incorporation into treatment plans for patients with complex perianal fistulas (CPF) due to Crohn’s disease (CD); Identify the role of magnetic resonance imaging in the assessment of CPF and treatment response in patients with CD; and Propose multidisciplinary care plans for patients with CPF due to CD.

Visit https://www.peervoice.com/CPJ860 to view the entire programme with slides. After completing “Angela Lamarca, MD, PhD, MSc - Overcoming Barriers to Better Care in CCA: Keys to Optimising Multidisciplinary Care, Molecular Testing, and Targeted Treatment”, participants will be able to: Apply guideline recommendations for molecular testing and targeted treatment in patients with cholangiocarcinoma (CCA); Propose practical approaches for improved multidisciplinary team communication and collaboration across the care continuum for CCA; and Identify strategies to overcome common barriers to optimised molecular testing in patients with CCA.

Visit https://www.peervoice.com/TKB860 to view the entire programme with slides. After completing “Andreas Kremer, MD, PhD, MHBA - Initiating the Conversation on Itch: Modelling Best Practices in Patient-Centred Care for Cholestatic Pruritus in PBC”, participants will be able to: Describe the impact of uncontrolled cholestatic pruritus on patient quality of life, mental health, and overall outcomes in primary biliary cholangitis (PBC); Summarise key patient counselling and education points related to cholestatic pruritus in PBC; and Incorporate effective communication and information-gathering strategies to improve evaluation of cholestatic pruritus in PBC.

Visit https://www.peervoice.com/KQF860 to view the entire programme with slides. After completing “Andreas Kremer, MD, PhD, MHBA - Incorporating the Investigation of Itch Into the Patient Care Process for PBC: Practical Steps, Tips, and Tools”, participants will be able to: Recognise the consequences of uncontrolled cholestatic pruritus on quality of life and outcomes in patients with primary biliary cholangitis (PBC); Demonstrate ability to use effective strategies when discussing and evaluating cholestatic pruritus in patients with PBC; and Evaluate both current and novel investigational strategies for management of cholestatic pruritus.